Trial Profile
Posaconazole Dug-Drug interaction study with Lurasidone in Healthy Obese subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Sep 2018
Price :
$35
*
At a glance
- Drugs Lurasidone (Primary) ; Posaconazole
- Indications Autistic disorder; Bipolar depression; Bipolar disorders; Major depressive disorder; Psychiatric disorders; Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- 01 Sep 2018 Results published in theClinical Pharmacology in Drug Development Conference: 2018 Annual Meeting of the American College of Clinical Pharmacology
- 11 Jun 2018 New trial record
- 30 May 2018 Results published in the Journal of Clinical Psychopharmacology